University of Wyoming
School of Pharmacy
Professional Pharmacy Program
2006-2007 Annual Report
Section 1: Introduction
The 2006-07 Academic Year has been an extremely busy year for the Faculty, Staff and
Administration of the University of Wyoming, School of Pharmacy. In addition to the usual
yearly work load this year, we prepared the self-study for the Accreditation Council for
Pharmacy Education (ACPE) accreditation site-visit which occurred in late April.
The ACPE developed new Standards and Guidelines as well as a new process of review,
mandated by the U.S. Department of Education, which will become official on July 1, 2007.
The school was given the option of being reviewed under either the old or new standards
and we chose to be reviewed under the new standards. Although the results of this
accreditation visit will not be available until July 2007 after the ACPE council meeting in
June, preliminary results have been shared with the school.
This is the 60th anniversary of the founding of the School of Pharmacy by Dean David W.
O’Day. A banquet recognizing the event was held in conjunction with the Annual Honors
and Awards Banquet. A capital campaign for the School was begun in his name.
The additional work load did not deter the School from experiencing another outstanding
academic year in teaching, scholarship, service and advising. The highlights of the year are
enumerated below:
 One new Associate Professor position was filled in Social and Administrative
Pharmacy
 A search for an Assistant Professor position in Clinical Practice was successfully
conducted for a position in Swedish Medical Center in Denver. This person will
join our faculty in August 2007
 A national search is being conducting for an Assistant Professor in
Pathophysiology and for an Assistant Professor in Toxicology. These will be
completed prior to July 2007.
 The UW Board of Trustees accepted our request for an additional Associate
Professor in Clinical Practice, a 0.5 FTE staff position and additional resources to
complete the position for an Assistant Professor of Clinical Practice. An increase
in differential tuition will pay for these positions.
 The school received 642 applicants for the 52 positions for next year’s entering
class. One hundred fifty (150) applicants were interviewed by the faculty before
selecting 52 for the new class.
 The faculty and researchers in the Center for Cardiovascular Research and
Alternative Medicine (C-CRAM) published 37 papers, made 9 national and
international presentations, one book review and presented 3 seminars.
 Faculty in the School of Pharmacy but outside of the C-CRAM had a total of 31
publications, 77 presentations and 13 publication reviews.
1









Dr. Sreejayan and Dr. Dolence were successful in receiving patents on two
products.
New and renewed grants total $1,178,408. In addition, there are $2.5 million in
grants pending. Five grants were inside the C-CRAM group and three were
received by faculty outside the C-CRAM unit.
Feng Dong, Research Scientist, received the Outstanding Dissertation Award from
UW’s Graduate School in recognition of his excellent graduate work –“Role of
Leptin in Obesity-associated Cardiac Dysfunction”. He was mentored by Jun Ren,
Professor of Pharmacology and Physiology.
The School of Pharmacy faculty received four (4) of the CHS recognition awards:
Chloe Jones – Staff Award, Dr. Allyn Ontko - Teacher Award, Dr. Kem Krueger
– Interdisciplinary Research Award, and Dr. Shiyan Li – New Investigator Award.
UW Ellbogen teaching award was awarded to Dr. Allyn Ontko a Medicinal
Chemist in the School of Pharmacy
Chloe Jones has developed a new newsletter named Wyoming Scripts and a new web
page enabling the school to better communicate with our graduates and the public.
Over 1100 requests for drug information from professionals and citizens in
Wyoming were handled by Melissa Hunter in the Drug Information Center.
Dean Vandel was elected by the American Pharmacist Association (APhA) to the
position of 2007-2008 Honorary President. He was installed in April 2007
The 2006 graduates from the School of Pharmacy passed their national exams for
licensure with the school average being above the national school average.
The School of Pharmacy has been making commendable progress in moving our school to a
level of excellence in teaching and research desired by our faculty, administration and the
College of Health Sciences.
Section 2: Academic Plan Implementation
School of Pharmacy Academic Plan II Action Item Status 2006-2007
Achievement 1.0. Develop Advanced Experiential Community Pharmacy Practice Sites to
enhance academic rigor, academic performance and student/faculty satisfaction.
Action Item 1: Partner with community pharmacists/pharmacies to develop
advanced experiential community practice sites. This partnership will lead to
expanded patient focused services, the development of practical, workable business
models and an enriched educational environment for our students.
Status for 2006-2007—currently, have 11 advanced community sites working
with the program.
Action item 2: Hire 2 FTE at the Assistant Clinical Professor level to develop
advanced experiential community practice sites in Wyoming. One site, Express
Pharmacy, in Laramie is currently being developed. Other potential sites exist
throughout the state in places such as Cheyenne, Casper and Powell. These initial
sites will serve as models and training environments for other pharmacists in the
state. From these “seeds” a network of advanced experiential community practice
2
sites should grow. Discussions are ongoing to look at potential shared positions with
major corporations such as Albertson’s and Walgreen’s. Outside of the state in
Colorado, integrated health care systems, such as Kaiser Permanente, already offer
advanced experiential community practice models. We have started to place some of
our students in these sites, but space is limited.
Status for 2006-2007—currently, have 11 advanced community sites working
with the program. This is adequate for all of our P4 students to participate in
an advanced community rotation.
Action item 3: Acquire funding and resources to conduct a multidisciplinary
“Wellness Clinic” in the College of Health Sciences.
Status for 2006-2007—No change in status
Action item 4: Continue efforts to develop and acquire funding for a pharmacy
faculty/student run “Refill Clinic” at the Downtown Clinic.
Status for 2006-2007—this action item has been fulfilled and continues to be
successful. This allows the Downtown Clinic to serve as an advanced
community site.
Action item 5: Acquire funding and resources to develop a Telepharmacy Practice at
the Cheyenne Family Practice Pine Bluff’s Clinic.
Status for 2006-2007— The Pine Bluff’s Clinic with the Telepharmacy
component went live in February 2007.
Achievement 2.0: Develop Advanced Experiential Acute-Care Institutional Practice Sites to
enhance academic rigor, academic performance and student/faculty satisfaction.
Action Item 6: Partner with integrated health care systems with large institutional inpatient populations to develop advanced experiential acute-care practice sites. This
partnership will lead to expanded patient focused pharmacist-provided services, the
development of practical, workable business models and an enriched educational
environment for our students.
Status for 2006-2007— the internal medicine faculty who are working with the
institutions on this aspect have been with the School of Pharmacy for at least
two years now. This area is still a work in progress.
Action item 7: Hire 2 FTE at the Assistant Clinical Professor level to develop
advanced experiential acute-care institutional practice sites. Discussions are on-going
with Banner Health in Greeley at the North Colorado Medical Center and Kaiser
Permanente in Northern Colorado. With the development of practices that bring
money into the institution, shared salaried positions are feasible and the instructor to
student ratio will be normalized.
Status for 2006-2007—currently, another new position has been authorized
and the search is in the planning stage. This should fulfill the action plan
item.
Achievement 3.0: Develop and Improve Programmatic Assessment (Formative and
Summative):
3
Action Item 9: To hold a faculty retreat that is led by a consultant that is a pharmacytrained outcomes assessment expert for proper guidance on assessment and
outcomes evaluation.
Status for 2006-2007—four faculty members and the Dean will be attending
the AACP Institute June 4-7, 2007. This institute will involve extensive
training in assessment and outcomes. Then, this group will return to assist
the rest of the faculty.
Action Item 10: Designate an Assessment and Outcomes Working Group
Status for 2006-2007—this group is working constantly. The chair is one of
the institute participants.
Action Item 11: To review current assessment methods from other SOPs and rank
them in terms of feasibility and information yielded.
Status for 2006-2007—four faculty members and the Dean will be attending
the AACP Institute June 4-7, 2007. This institute will involve extensive
training in assessment and outcomes by experts and faculty from other
Schools of Pharmacy.
Action Item 12: Require each standing SOP committee to integrate and implement
continued assessment process into their committee charges.
Status for 2006-2007— Progress has been made. Pointers from the AACP
Institute will assist in this process.
Action Item 13: Integrate the recommendations from the Assessment and
Outcomes Working Group into the curriculum on a continuing basis.
Status for 2006-2007—Progress has been made, but more work is needed.
Pointers from the institute will assist in this process.
Action Item 14: Collect and analyze assessment outcome data and provide
recommendations for curricular change yearly [at a minimum].
Status for 2006-2007 – The data are analyzed and presented to the faculty and
individual instructors. The emphasis is change within the current curricular
structure, with a goal for Academic Plan III to be an overall evaluation of the
current curriculum and make major structural changes at one time.
Achievement 4.0: Develop Interdisciplinary Graduate Programs in the Life Sciences:
Action item 15: The faculty of the School of Pharmacy will work with the Dean of
the Graduate School and the Dean of the College of Health Sciences to explore
participation in existing interdisciplinary doctoral programs (e.g. Microbiology,
Neuroscience, etc.) to enhance both the research environments in respective units
and to benefit from shared research resources available through those doctoral
programs.
Status for 2006-2007— Talks with several units within and outside the College
of Health Sciences are on-going.
4
Action item 16: Appropriate faculty in the School of Pharmacy will work with the
Deans of Agriculture, Arts and Sciences and Health, to develop a broad based,
interdisciplinary doctoral program in the Molecular and Cellular Life Sciences.
Status for 2006-2007— Talks with several units within and outside the College
of Health Sciences are on-going.
Action Item 17: To enhance research productivity and acquire a critical mass of
research productive faculty in the SoP, additional faculty members are needed in the
areas of Social and Administrative Pharmacy (SAP). The SoP had three SAP faculty
but one position was vacated when Dr. Ranelli left. The two remaining SAP faculty
are overburdened with teaching, leaving less time for research.
Status for 2006-2007— Dr. Kem Krueger joined the Social and Administrative
Pharmacy faculty in the fall of 2006.
Action Item 18: To enhance research productivity and acquire a critical mass of
research productive faculty in the SoP, additional faculty are needed in Toxicology/
Pharmacology. A new faculty position will be requested to coordinate the teaching
of Toxicology. The pharmacologists in the SoP (Drs. Ren, Sreejayan, and Culver) are
presently helping a temporary lecturer, Dr. Rob Palmer, to team-teach this course.
However, these faculty members are research intensive and already have a full
teaching load in the 3 pharmacology courses, the Neuroscience course, and in
lecturing in the WWAMI pathology course. The addition of another
pharmacologist/toxicologist would alleviate the heavy teaching burden and would
hopefully enhance our research enterprise. Again, preference would be given to a
candidate with research interests compatible with those of others in the department.
Status for 2006-2007— Faculty positions in Toxicology and Pathophysiology
are currently in the interview stage. Anticipated start dates are fall 2007.
Achievement 5.0: To enhance teaching, service and research productivity, develop graduate
pharmacy practice residency programs in community and institutional health care
environments.
Action Item 19: Create a community-based residency program that is housed in an
advanced community pharmacy practice site. Explore funding of the community
residency by integrated health care systems [Kaiser, etc] or major pharmacy
corporations [Albertsons, WalMart, etc.]. Creation of a post-graduate residency will
enhance teaching, service and research productivity.
Status for 2006-2007 – talks are on-going.
Action Item 20: Create an institutional-based pharmacy practice residency program
that is housed in an advanced institutional acute-care pharmacy practice site.
Explore funding of the residency by integrated health care systems [Kaiser, etc].
Creation of a post-graduate residency will enhance teaching, service and research
productivity.
5
Status 2006-2007 - The new residency program at Cheyenne Regional Medical
Center has been approved, budgeted, and will have 2 residents beginning in
July 2007.
Achievement 6.0: Development of distance education technologies.
Action item 21: The School of Pharmacy will develop strategies and resources
necessary to the development of a telepharmacy program, connecting community
clinical training sites with the UW campus in Laramie, and facilitating faculty
development of adjunct faculty in distant clinical sites.
Action item 22: The School of Pharmacy will develop strategies for enhanced use of
distance education technologies and on-line instruction to permit engagement of
both professional on-campus and off-campus student populations.
Status 2006-2007 – Several faculty are using various platforms for their oncampus students. At least two service courses are offered via distance
technology for off-campus students. A few video conference lectures have
been presented by faculty and speakers outside of Laramie to students in oncampus classrooms.
Action Item 23: The School of Pharmacy will develop strategies for enhanced use of
distance education technologies and on-line instruction to permit engagement of
regional practitioners in continuing education for professional development.
Status 2006-2007—This action item has not been implemented, but as
experience grows with the enrolled students, this should be reviewed.
Achievement 7.0: Professional Faculty and Adjunct Faculty Development Programs –
Action Item 24: Create faculty development committee that will gather information
about existing mentoring and faculty development programs [here and elsewhere]
and make recommendations to the Dean, the Dean’s Advisory Council and the
faculty.
Status 2006-2007 – The faculty development committee has been very active in
the last couple of years. This action item is fulfilled.
Action Item 25: Create a Dean’s Advisory Council composed of off-campus
practitioners, educators and influential individuals that will make recommendations
regarding faculty development.
Status 2006-2007 – The Dean’s Advisory Council has been very active in the
last couple of years. This action item is fulfilled.
Action Item 26: Administer a needs assessment survey to faculty and adjunct faculty.
Status 2006-2007 – Completion of this action item is anticipated in 2008-2009.
Preliminary surveys have been conducted.
Action Item 27: Hire 1.0 FTE APL pharmacist experiential coordinator to assess,
coordinate and implement faculty development programs for practice and adjunct
faculty.
6
Status 2006-2007 – This has not been fulfilled at this time.
Action Item 28: Begin a regular seminar series for all teaching and research faculty to
improve mentoring and collaboration.
Status 2006-2007 – The Pharmaceutical Sciences Division has sponsored this
series for the last three years. This has been a successful endeavor.
Action Item 29: Initiate regional meetings for practice adjunct faculty two times a
year for coordination and development purposes.
Status 2006-2007 – This has not been fulfilled at this time.
Section 3: Teaching Activities
The department encourages and rewards high quality teaching and curriculum development
through School, College and University awards for teaching excellence which were awarded
to our faculty. The department meetings and committee meetings encourage open
discussion of topics and ideas for curricular development and teaching techniques used by
other faculty. During the past year 1 new elective course was developed and 2 additional
elective courses have been developed for next fall.
Section 4: Research/Creative Activities
The Pharmacy Practice Division consists of 12 faculty, one Academic Professional, one
Research Scientist and a Director. Portions of job descriptions for these individuals relating
to scholarly activity range from 0 - 15%. Given teaching loads and self-study assignments for
some individuals, faculty productivity in this area met or exceeded expectations for AY
2006-2007. Please see attached list of publications, presentation, articles etc. Over all
research for the basic science faculty in the School of Pharmacy is meeting expectations.
Research in CRAM is exceeding expectations and inspiring other faculty research.
Section 5: Service, Extension and Outreach Activities:
The School of Pharmacy has faculty and staff on college and university committees. The
school has three main areas of service in our WYDrug Utilization Review, Drug Information
Center and as a provider of CE.
The goal of WYDUR is to enhance the quality of care for patients by assuring appropriate
drug therapy to include optimal patient outcomes and appropriate education for
practitioners, dispensers and the patient. The clinical and economic analyses will be
performed in the context of health system benefits and costs. The Drug Utilization Review
(DUR) program held six DUR Board meetings where drug-related issues were discussed.
The Board, made up of five physicians, five pharmacists and a physician’s assistant,
guides the DUR program’s prospective and retrospective drug utilization review
processes. The Board sent out more than 750 provider education letters regarding
specific drug problems in Medicaid recipients. In addition, four quarterly newsletters
were sent out to approximately 2100 physicians, nurse practitioners, physician’s
assistants and pharmacists in Wyoming. The DUR program collaborated with the
Department of Health’s disease management contractor (APS Healthcare, Inc.) and
Berlex to provide an educational program on multiple sclerosis. This program consisted
7
of a web CE program as well as mailings to affected Medicaid recipients and their
providers.
The University of Wyoming Drug Information Center (DIC), operated by Melissa L Hunter
Pharm.D. D. RPh, provides its services to the people of Wyoming, as well as alumni
graduated from the School of Pharmacy. Services include, but are not limited to: pill
identification, drug interaction identification, adverse drug event evaluation, drug dose
suggestions, and drug therapy alternatives. While any citizen in Wyoming can utilize the
service, most of the requests come from pharmacists, followed by chemists, nurses and
physicians. Over 1100 questions have been answered this past year. The DIC also served as
a rotation site for five students, with seven rotations assigned for the upcoming year. The
DIC is continuing to advertise through brochures and magnets.
Continuing education activities have, with the assistance of Dean, Tia Farmer, various
faculty, Wyoming Department of Health staff and the two major pharmacy associations,
provided a variety of live learning opportunities in several locations. The Pharmacy
Weekend (September) focused on Pandemic Flu, drew positive attention from the campus
and the community as well as the participants. Collaboration with the state diabetes
educators led to ACPE accreditation for 10 hours of programming at their annual meeting
(September.) A certificate program, sponsored by APhA on immunization techniques
(January) served several members of the Class of 2007, as well as pharmacists from military
and chain pharmacy operations. A guide for CE program planners will assist them in
meeting ACPE requirements
Section 6: Student Recruitment and Retention Activities and Enrollment Trends:
The School of Pharmacy has two types of students: preprofessional and professional
students. Preprofessional students are undergraduate students completing prerequisites in
order to apply to the professional program. Professional students are students who have
gained admittance into the program; they are classified by year P1, P2, P3 and P4. For the
first two years of the professional program students are considered undergraduate students
for financial aid purposes and in the last two years considered graduate students for financial
aid purposes. The school has recently passed new standards for the preprofessional
program. Starting with freshman in the academic year 2007-2008, only students who score
23 or above on their math ACT or get a 3 or better on the math placement will be allowed
to declare prepharmacy. Students who do not meet this standard will be sent to HLSC
undeclared until their math scores are sufficient to join the preprofessional program.
Students who are trying to transfer to the preprofessional program will need at least a 3.0
GPA.
Currently we have between 150-180 preprofessional students. This number varies on a
regular basis because students add and drop the preprofessional program often. This is one
trend we hope will change with the change in the preprofessional standards. At the time of
this report there were are 150 preprofessional students. There are currently 199 students in
the professional program. Each professional class has 52 seats, but enrollment varies from
class to class if students have had academic trouble and are on probation. Usually academic
trouble causes students to be held back a year.
8
Students can only obtain one degree from the School of Pharmacy and that is the Pharm.D.,
students complete 142 hours in the four year professional program. This is above and
beyond the 67 hours required of the preprofessional program. The School of Pharmacy
increased the class size with the class of 2008 to 52 students. Again numbers vary between
years due to students falling behind and joining other classes, students who leave or are
asked to leave the program.
Class of
2007
2006
2005
2004
2003
Number of Graduates
46
43
47
46
41
Hours
142/per student
142/per student
142/per student
142/per student
142/per student
Admitted
48
48
48
48
48
We recruit for the professional program by attending professional and graduate fairs around
the area; we visit most Wyoming Community Colleges and rely on our website and the
PharmCAS website. We recruit for the preprofessional program by attending Discovery
Days, and visiting with interested students via the Visitor Information Center. A large
number of our referrals come from previous alumni. The focus of any recruitment effort is
on the competitive nature of the program and the need for academic excellence. Students
are informed up front about the difficulty getting into the program, and rigor they face in the
program. Our focus is not on numbers but on solid candidates that will be successful in our
program. We highlight our class size and attention to students, our impressive pass rate and
salary/benefits of Wyoming Pharmacy Graduates.
Students in the preprofessional program are advised by Maria Bennett, the Credentials
Analyst/Academic Advisor. Students are encouraged to use their advisor as a resource, the
CAAA does not have any office hours, and students are encouraged to drop in and to utilize
e-mail. We help obtain tutors and encourage students to seek academic help if needed.
Students are kept aware of their academic performance and how it affects their chances of
getting into the program. Students who are not making the grade are encouraged to change
majors, they don’t have to give up on applying to program, but they require more time to
mature and improve academic performance. No student should spin wheels and should
always be moving toward a degree. Students in the professional program are monitored and
advised by faculty members. They are encouraged to use their advisor as a resource, and
advisors are contacted, usually by the professor, when the student is having academic
trouble. The faculty is the first to help and are proactive about helping students who are in
trouble in their courses. Being a small program we can give extra attention to students in
need.
Section 7: Development activities and public relations.
The most notable activity this year was the announcement by the Dean to launch the David
W. O’Day Campaign to raise $1.5 million that will be matched by the State of Wyoming for
a total of $3 million; this campaign is an umbrella that will encompass and encourage other
contributions and gifts.
9















Foundation gifts and interest for FY 06-07 to-date total $100,620.
The Dean’s Honor Roll is continuing to gain recognition. Plans are underway to
recognize donors by placing their names on an “Honor Board” which will be located
in the main hallway of the school.
Our new alumni newsletter and development piece, Wyoming Scripts, highlights
activities of the school and annually recognizes donors.
The Annual Honors and Awards Banquet and 60th Anniversary Celebration on April
21, 2007 honored and recognized donors. Plans for future banquets are to include
donors each year.
The school utilized the services of UW Photo Service to take photos of donors and
their scholarship winners at the banquet to publish in the next newsletter, use for
news articles on the school’s Web site and to share with other agencies or
publications connected to the donors (e.g. University of Wyoming, College of Health
Sciences, Wyoming Pharmacy Association, and The Denver Hospice newsletter).
Thank you letters from the Dean are sent to donors as a personal thank you for their
gifts to the school. The letters outline how the school has used the gifts to benefit
students and faculty.
$27,675 dollars in scholarships given to 33 students.
The school uses Foundation contributions and gifts for scholarships as specified by
donors.
12 students were sent to 4 national meetings during FY 06-07 with the help of
sponsors and donors.
The Otis L. Hoy Memorial Seminar fund is growing. Pharmacy Weekend events
such as the Hoy Seminar, advisory committee meetings, C.E. and tailgate are ways
the school increases awareness of alumni and donors.
The school now uses the Foundation database for alumni and donors instead of
trying to maintain a separate database. Address and contact information changes
received at the school are forwarded to Foundation to verify and change in the
database. Data request forms are submitted to Foundation for information needed
to send thank you letters publish donor lists in the newsletter, send publications or
mailings and invite donors and alumni to special events.
Working with Foundation we have identified donors, both corporate and individual,
to contact to discuss options for giving to the school.
Plans are to cultivate identified donors and pursue solicitation by asking them to
contribute to the O’Day Campaign or areas that fall under the umbrella of the
campaign in order to obtain matching funds from the state.
Plans are to use teamwork to keep development activities alive and to work in
conjunction with the College of Health Sciences, UW Foundation and UW Public
Relations.
Services of the Development Officer are sorely missed.
The school has been very actively involved in the public relations area thanks to the efforts
and iniative of Chloe Jones and has teamed with the UW Public Relations office and by
utilizing their expert services has developed a new, more professional, newsletter format and
has updated the school’s Web site using UW’s “content management system”. This allows
for a more dynamic format for content and photos and makes the site more interesting. In
10
addition, professional photos taken by UW Photo Service have greatly enhanced the
newsletter, Web site and press releases. Accomplishments by students, faculty and
researchers have gained attention through UW Media Relations press releases and activities
about the 60th Anniversary of the founding of the school have been a central theme for
many articles and events.










The school has invited well-known speakers for the Otis L. Hoy Memorial Seminar
series held in the fall each year. Two of the recent keynote speakers were Dr. John
Gans, Executive Vice President of The American Pharmacists Association and Dr.
Brent Sherard, Director of the Wyoming Department of Health.
Wyoming Scripts, the school’s new newsletter, was distributed to school alumni,
donors, vendors, other schools and colleges of pharmacy, current students, faculty
and staff, CHS departments, and the UW administration. The publication will be
used for recruiting students and fundraising by the school.
o Nine UW press releases have been generated over the last year to highlight
student, faculty, researchers and school activities.
In addition to UW press releases, faculty, researchers, students, alumni and school
activities are highlighted in various feature articles on the Web site under the school
News section.
The Faculty and Staff Web page has been re-designed allowing for more in-depth
information to be presented on each faculty member in the areas of research,
teaching, service and publications.
The old pharmacy alumni Web site has been re-designed and moved to a prominent
page on the pharmacy site and updated to a more dynamic style which will feature
photos and articles about alumni. Alumni are encouraged to send in photos and
items for news articles. This move also allows for more integration with current
news stories, events and announcements and provides ease of navigation through all
the pharmacy information.
As the pharmacy Web site is dynamic, it is always changing. Future upgrades include
a Question/Comment section, news or event submission section and utilizing the
Calendar of Events to list all events for students, alumni, faculty and staff. We are
discussing the use of videos and more imagery. Plans include publishing a virtual
tour of the school. The school recognizes that the improvements and maintenance
of the Web site also impacts the UW Web Design team’s resources and appreciates
their efforts despite their few staff.
The school’s Web site contains admissions information and links for prospective
students for application and testing information. A new section for Frequently
Asked Questions (FAQs) has been added and will be updated each admissions cycle.
Current students can still find links to online resource information and Student
Affairs information (e.g. Student Handbook and Student Honor Code).
Students on rotations can also use the links provided to access the Professional
Experience Web site.
Course information (e.g. notes and handouts) has been moved to other online
applications through the WyoWeb portal such as Course Studio, eCompanion or
11
WebCT. Students are also advised to use the Pharmacy Students Group on
WyoWeb which contains resource links and files.
Section 8: Classified and Professional Staffing:
The school has been successful in filling several faculty positions and has made gains in
getting approval for needed positions. However, during the on-site visit in April 2007, the
ACPE accrediting board indicated their report would stress that we are not meeting the
standards in the area of organization and governance. The report will suggest that the
school needs an Associate Dean, Assistant Dean and a Director of Student Affairs and is in
desperate need of adequate staffing. The school also needs and will be requesting an
Assistant Professor of Social and Administrative Pharmacy.
The administrative assistant in the professional experience and CE programs is leaving to
take a new position at UW. We will be filling this position soon to begin training. ACPE
stressed the need for new staff to help in the area of student affairs and data management.
We will be requesting additional staff to assist in these areas.









Dr. Kem Krueger was hired as Associate Professor of Social and Administrative
Pharmacy, with emphasis on Pharmacoeconomics and Health Outcomes Research
Dr. Melissa Hunter was hired as the Drug Information Director.
Dr. Aimee Lewis was hired as the Director of the Drug Utilization Review (DUR)
program.
The school is currently advertising and interviewing for two faculty positions:
Assistant Professor of Pathophysiology (position previously held by Dr. Hal
Bruyere) and Assistant Professor of Toxicology. Both positions will be filled this
summer.
The Swedish Family Medicine Clinical Assistant Professor of Pharmacy Practice
ambulatory care position was filled by hiring Dr. Mary Emashowski who will be
joining us later this summer.
Tia Farmer’s Office Assistant Senior position was upgraded to Office Associate.
This the administrative assistant position for the professional experience and CE
programs.
The school gained 0.5 FTE for an office assistant position for the main office.
Another 0.5 FTE staff position will be added effective July 2007, approved by UW
Board of Trustees in January 2007.
0.5 FTE staff position being lost on June 30, 2007 as a result of the Wyoming
Department of Health bringing the Wyoming PharmAssist program in-house.
Section 9: Diversity
A search for a non-tenure tract pharmacy practice faculty was conducted during AY 20062007. The usual course for hiring pharmacy practice faculty is to advertise through and
recruit at the American Society of Health Systems Pharmacists (ASHP) Mid-year Meeting in
December. Each advertisement contains the statement, “The University of Wyoming is an
Affirmative Action/Equal Opportunity Employer.” All recruitment and hiring activities are
approved by the University Employment Practices Officer.
12
Following approval of a Search Plan and permission to proceed, 12 candidates were
interviewed at the ASHP Mid-year meeting in December. Two additional candidates sent
CVs but were not available for interview. Five candidates were white males, eight candidates
were white females and one candidate was an Asian female. Four candidates were selected by
the school search committee for campus interviews and three responded. One male and two
females (one white, one Asian) were interviewed on campus. The job was offered to a white
female who accepted.
Section 10: Assessment of Student Learning:
Program goals and student learning outcomes for the Doctor of Pharmacy program are
based on the 2004 CAPE (Center for the Advancement of Pharmaceutical Education)
outcomes which were revised during 2003-2004. These outcomes have been incorporated
into the ACPE (Accreditation Council for Pharmacy Education) Accreditation Standards
and Guidelines for the Professional Degree Program in Pharmacy Leading to the Doctor of
Pharmacy Degree. The 2004 CAPE outcomes are available on the AACP (American
Association of Colleges of Pharmacy) website:
http://www.aacp.org/site/page.asp?TRACKID=&VID=1&CID=1031&DID=6074.
CAPE outcomes are available to students through the School of Pharmacy website:
http://uwadmnweb.uwyo.edu/Pharmacy/.
Assessment activities for AY 2006-2007 included:








Graduating Student Exit Interview: a student review of the curriculum from prepharmacy through the fourth professional year
Preparedness Survey: administered to students entering and exiting the fourth
professional year
Student Curriculum Advisory Committee, Preceptor Advisory Committee
P4 Professional Portfolio: contains documentation of patient care, interventions,
professional writing and presentations; newly added for AY 2007-2008 are three
reflective writings.
Patient Demographics: data demonstrate patient diversity and patient care
opportunities in faculty-led experiential courses; new for AY 2006-2007
ACPE Standards 12/14 Survey: demonstrates patient care opportunity (discovery
experiences) for students in faculty-led experiential courses and documents activities
in student portfolios
Renal Function Assessment Project: demonstration of student opportunity in the
analysis and communication of medication dosage based on renal function; based on
a curricular mapping exercise completed AY 2005-2006.
AACP Graduating Student Survey, Alumni Survey, Faculty Survey: three new
surveys (AY 2006-2007) administered by AACP for ACPE
Outcomes of assessment activities are usually reviewed by the School of Pharmacy
Assessment Committee during the summer and a report with recommendations is made to
the faculty at a faculty retreat in August.
13
The School of Pharmacy recently completed a self-study and site review by a team
representing the Accreditation Council for Pharmacy Education. Curricular and student
outcome assessment for the next academic year will be heavily influenced by the ACPE
report which is due July 2007. Anticipated beginning activity includes curricular mapping of
the 2004 CAPE outcomes.
The term “discovery experience” may be applied to experiential courses (or rotations). A
major goal of these courses is application of knowledge, skills and behaviors obtained from
early didactic courses to patient care activities. In response to ACPE requirements, early
experiential coursework in institutional and community pharmacy now follows the end of
the first professional year. Ideally, some learning activities relate to completed coursework
including microbiology, physiology, pathophysiology and pharmaceutics. Advanced courses
in institutional and community pharmacy are then completed during the fourth professional
year. Many, but not all, fourth year experiential courses build on preceding courses. For
example, Internal medicine II follows Internal Medicine I and the elective Ambulatory
Pharmaceutical Care II follows the required Ambulatory Pharmaceutical Care I. Students
actively engage patient care in a variety of settings and, to the extent possible, pharmaceutical
care is provided in cooperation with patients and other health providers using sound
therapeutic principles and evidence based data. Patient care plans are designed, monitored,
evaluated and adjusted while communicating with patients and health care providers.
Professional and scientific literature is used to support patient care plans and
recommendations to providers. CAPE educational outcomes, therefore, are embedded in
experiential course activities. Student outcomes from many experiential courses are
documented in the professional portfolio which contains examples of patient care plans,
interventions and written and verbal communication.
14
Refereed Articles for Practice Faculty:
Hilaire ML, Wozniak JR. Xopenex HFA for treatment of bronchospasm. American Family
Physician 2007;75(2):246-48.
Yamreudeewong W, Dolence EK, Pahl D. Stability of two extemporaneously prepared oral
metoprolol and carvedilol liquids. Hospital Pharmacy 2006;41:254-9 (data based).
Yamreudeewong W, Teixeira MG, Mayer GE. Stability of memantine in an extemporaneously
prepared oral liquid. International Journal of Pharmaceutical Compounding 2006;316-7
(data based).
Stump A, Kelley K, Wensel T. "Bazedoxifene: a third generation selective estrogen receptor
modulator." Annals Pharmacother. 2007; 41: 833-839.
Stump A, Mayo T, Blum A. "Management of Grapefruit-Drug Interactions." Am Fam Physician.
2006; 74: 6005-8, 611.
Textbooks:
Graham AC, Wesnitzer R. Skin and soft tissue infections. Chapter 65. In: Chisolm M, et al.
Pharmacotherapy Principles & Practice. (1st ed.) New York: McGraw-Hill, 2007. In press
Graham AC, Mercier RC. Diabetic foot infection. In: Schwinghammer TL. Pharmacotherapy
Casebook: a Patient-focused Approach. (7th ed.) New York: McGraw-Hill, 2007. In press
Mercier RC, Graham AC. Intra-abdominal infection. In: Schwinghammer TL. Pharmacotherapy
Casebook: a Patient-focused Approach. (7th ed.) New York: McGraw-Hill, 2007. In press
Abstracts:
Petrie J, Burman M, Buller L. Implementation of appointment-based lab
services in a free clinic. JAPhA 2007;47(No 2):208.
Yamreudeewong W, Teixeira MG, Mayer GE. “Stability of levalbuterol in a mixture of
levalbuterol and ipratropium nebulizer solution” Forty-first American Society of Health-System
Pharmacists Annual Midyear Clinical Meeting, December 4-7, 2006, Anaheim, California
(abstract).
Oral Presentations:
Goodell M, Hilaire ML, Musil B. The use of games to enhance resident education in
pharmacotherapy.-Lecture Discussion Society of Teachers of Family Medicine (STFM) Annual
Spring Conference
April 2007, Chicago, IL.
"Venous Thromboembolism (VTE) Prophylaxis and Treatment: A Review of the Guidelines and
a Focus on Special Populations" - Invited presentation. St. John's Hospital, Jackson, WY. March,
22nd, 2007. Lunchtime CME"
15
"Overview of Common Medications Used in the Acute Care of Stroke" - Stroke Care is a Team
Effort: A Collaborative Approach to Improving the Outcome of Stroke. Hosted by Swedish
Medical Center and Colorado Neurobiological Institute. Denver, CO. December 2006.
"Venous Thromboembolism (VTE) Prophylaxis and Treatment: A Review of the Guidelines and
Application for the Primary Care Physician" - Colorado Academy of Family Physicians, Annual
'Reach Out' Conference. Denver, CO. November, 2006.
"Primary Prevention of Stroke: The Importance of Pharmacotherapy in an Integrated Healthcare
Approach" - University of Wyoming 'The Many Faces of Stroke' Seminar. October, 2006
"Excessive urinary bladder bleeding and epsilon aminocaproic acid" Platform presentation,
Clinical Pearls program, Forty-first Annual American Society of Health-System Pharmacists,
Midyear Clinical Meeting, Anaheim, California, December, 2006.
Posters:
Woods TM, Martin LG. Improving health outcomes through self-management
in senior citizens with diabetes. Poster Presentation. American
Pharmacist's Association, Atlanta, GA, March 2007.
Woods TM, Martin LG. Improving health outcomes through self-management
in senior citizens with diabetes. Poster Presentation. College of
Health Sciences Grand Rounds and 13th Annual Research Day, University of
Wyoming, April 2007.
Hilaire ML, Thomas J, Ables A, Franks A, Pelletier A. New Drugs 2007: Learning and Teaching
about New Drugs from the Group on Pharmacotherapy.- Scholastic poster
Society of Teachers of Family Medicine (STFM) Annual Spring Conference, April 2007,
Chicago, IL.
Hilaire ML, Marchant DR, Snook MS. Samples: Methods to improve patient safety and provider
satisfaction.- Scholastic poster, Society of Teachers of Family Medicine (STFM) Annual Spring
Conference, April 2007,
Chicago, IL.
Petrie JL, Burman ME, Buller L. Implementation of appointment-based lab
services in a free clinic. Poster presented at the American
Pharmaceutical Association Meeting March 2007.
Petrie JL, Burman ME, Buller L. Implementation of appointment-based lab
services in a free clinic. Poster presented at the University of Wyoming
College of Health Sciences Grand Rounds April 2007.
Grants:
5/2007 Albany County Community Service Block Grant, Discretionary Funding Funded by the
State of Wyoming
Amount $12,000.00. Type: Clinical Practice, PI: Johnson L, Petrie JL
16
9/2006 Guthrie Family Foundation Grant, Funded by the Guthrie Family Foundation. Amount:
$10,000.00
Type: Clinical Practice, PI: Johnson L, Petrie JL
8/2006 Albany County Community Service Block Grant, Funded by the State of Wyoming.
Amount: $13,500.00
Type: Clinical Practice. PI: Johnson L, Petrie JL
June, 2006 – present, Weeranuj Yamreudeewong, Pharm.D., P.I., with co-investigators from
University of Wyoming, Cheyenne Family Practice Residency Program. "Evaluating the effects
of psyllium on blood glucose and lipids in patients with type 2 diabetes mellitus". Funded by
Konsyl Pharmaceuticals, Inc., $16,923.20 (Konseal Pharmaceuticals agreed to provide extension
for the grant period).
July, 2005 – June 2006: A Pharmacy Practice Residency grant of $45,000 from Central Veterans
Administration Office in Washington, D.C., for supporting the Pharmacy Practice Residency
Program of Cheyenne VAMC/UW School of Pharmacy.
Other:
Petrie, J: Undergraduate and Graduate Student Research Supervision, 2/2007Senior Project Advisor, University of Wyoming Honors Program
ASHP AmbCare Clinical Care Guideline Workgroup: I am currently writing the sections on
starting a new service and addressing adherence issues/concepts.
17
C-CRAM 06-07 Fiscal Year Summary (2006.7.1-2007.6.30)
A. ARTICLE IN PEER-REVIEWED JOURNAL:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
Barceló-Coblijn G, Wold LE, Ren J, Murphy EJ. Prenatal ethanol exposure increases
brain cholesterol content in adult rats Lipids in press.
Dong F*, Yang X*, Sreejayan N, Ren J. Chromium (D-phenylalanine)3 improves
obesity-induced cardiac contractile defect in ob/ob mice. Obesity Res. in press. (*equal
first authorship)
Dong F, Ren J. Fidarestat improves cardiomyocyte contractile function in db/db
diabetic obese mice through a histone deacetylase Sir2-dependent mechanism. J.
Hypertens acceptable.
Dong F, Ren J. Fitness or fatness - the debate continues for the role of leptin in obesityassociated heart dysfunction. Curr Diabetes Rev. in press.
Dong F, Taylor MM, Samson WK, Ren J. Intermedin (Adrenomedullin-2) enhances
cardiac contractile function via a protein kinase C and protein kinase A-dependent
pathway in murine ventricular myocytes. J. Appl. Physiol. 101: 778-784, 2006.
Doser TA, Culver B, Ren J. COX-2 inhibitors and cardiovascular event: deja vu du jour.
Vascular Disease Prevention 3: 217-221, 2006.
Duan J, Dai S, Fang CX, Sun RY, Shavali S, Sharma SK, Ebadi M, Ren J.
Phytoestrogen α-zearalanol antagonizes homocysteine-induced imbalance of nitric
oxide/endothelin-1 and apoptosis in human umbilical vein endothelial cells
(HUVEC). Cell. Biochem. Biophys. 45: 137-145, 2006.
Duan J, Xu HS, Dai S, Wang X, Wu Y, Zhang Y, Sun R, Ren J. Phytoestrogen αzearalanol inhibits homocysteine-induced endothelin-1 expression and oxidative stress
in human umbilical vein endothelial cells. Atherosclerosis in press.
Ebadi M, Brown-Borg H, Ren J, Sharma S, Shavali S, El ReFaey H, Carlson EC.
Therapeutic efficacy of selegiline in neurodegenerative disorders and neurological
diseases. Curr Drug Targets 7:1513-1529, 2006.
Fang CX, Wu S, Ren J. Intracerebral hemorrhage elicits aberration in cardiomyocyte
contractile function and intracellular Ca2+ transients. Stroke 37: 1875-1882, 2006.
Fang CX, Yang X, Sreejayan N, Ren J. Acetaldehyde promotes rapamycin-dependent
activation of p70S6K and glucose uptake despite inhibition of Akt and mTOR in
dopaminergic SH-SY5Y human neuroblastoma cells. Exp. Neurol. 203:196-204, 2007.
Jay MA, Ren J. Peroxisome proliferator-activated receptor (PPAR) in metabolic
syndrome. Curr Diabetes Rev. 3: 33-39, 2007.
Li LL, Ma XL, Ran JX, Sun XF, Xu LM, Ren J, Mao XM. Genetic polymorphism of
peroxisome proliferator-activated receptor-[gamma]2 pro12Ala on ethnic susceptibility
to diabetes in Uygurs, Kazaks and Hans subjects. Clin Exp. Pharm. Physiol. in press.
Li Q, Fang CX, Nunn JM, Zhang J, LaCour KH, Ren J. Characterization of
cardiomyocyte excitation-contraction coupling in the FVB/N-C57BL/6 intercrossed
“chocolate” brown mice. Life Sci. 80:187-192, 2006.
Li Q, Ren J. Cardiac overexpression of metallothionein attenuates chronic alcohol
intake-induced cardiomyocyte contractile dysfunction. Cardiovasc. Toxicol. 6: 173182, 2006.
18
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
Li Q, Ren J. Cardiac overexpression of metallothionein rescues chronic alcohol intakeinduced cardiomyocyte dysfunction: Role of Akt, mammalian target of rapamycin and
ribosomal p70s6 kinase. Alcohol Alcoholism 41: 585-592, 2006.
Li Q, Ren J. Chronic alcohol consumption reduces activation of mammalian target of
rapamycin (mTOR) and ribosomal p70S6 kinase in cerebral cortex. Exp. Neurol.
204:840-844, 2007.
Li Q, Ren J. Influence of cardiac specific overexpression of insulin-like growth factor-1
on life span and aging-associated changes in cardiac intracellular Ca2+ homeostasis,
protein damage and apoptotic protein expression. Aging Cell acceptable.
Li Q, Wu S, Li SY, Lopez FL, Du M, Kajstura J, Anversa P, Ren J. Cardiac specific
overexpression of insulin-like growth factor-1 (IGF-1) attenuates aging-associated
cardiac diastolic contractile dysfunction and protein damage. Am J Physiol: Heart Circ
Physiol 292: H1398-H1403, 2007.
Li Q, Yang X, Sreejayan N, Ren J. Insulin-like growth factor I deficiency prolongs
survival and antagonizes paraquat–induced cardiomyocyte dysfunction: Role of
oxidative stress. Rejuv Res. acceptable.
Li SY, Sigmon VK, Babcock SA, Ren J. Advanced glycation endproducts induce ROS
accumulation, apoptosis, MAP kinase activation and nuclear O-glcNAcylation in
human cardiac myocytes. Life Sci 80:1051-1056, 2007.
Relling DP, Esberg LB, Johnson WT, Murphy EJ, Carlson EC, Saari JT, Lukaski HC,
Ren J. Dietary interaction of high fat and marginal copper deficiency on cardiac
contractile function. Obesity Res. in press.
Ren J, Duan J, Thomas DP, Yang X, Sreejayan N, Sowers JR, Leri A, Kajstura J,
Anversa P. IGF-1 alleviates diabetes-induced RhoA activation, eNOS uncoupling and
myocardial contractile dysfunction. Eur. Heart J. acceptable.
Ren J, Li Q, Wu S, Li SY, Babcock SA. Cardiac overexpression of antioxidant catalase
attenuates aging-induced cardiomyocyte relaxation dysfunction. Mech. Aging Dev. 128:
276-285, 2007.
Ren J, Privratsky JR, Dong F, Carlson EC, Yang X. Metallothionein prevents
glutathione depletion-induced oxidative cardiomyopathy in murine hearts.
Hypertension acceptable.
Ren J. Acetaldehyde and alcoholic cardiomyopathy: lessons from the ADH and ALDH2 transgenic models. Novartis. Found. Symp. in press.
Ren J. Influence of gender on oxidative stress, lipid peroxidation, protein damage and
apoptosis in hearts and brains from spontaneously hypertensive rats. Clin. Exp. Pharm.
Physiol. 34: 432-438, 2007.
Ren J. Interaction between high fat diet and ADH on ethanol-elicited cardiac
depression in murine myocytes. Obesity Res. in press.
Ren J. Pharmacology of the 21st century: bridging the past and forefront of molecular
medicine. New Drug Invest. Tribune 28:7, 2006
Ren J. New technology, new concept - American College of Cardiology 2007. New
Drug Invest. Tribune in press
Saari JT, Wold LE, Duan J, Ren J, Carlson HL, Bode AM, Lentsch AB, Zeng H,
Schuschke DA. Cardiac nitric oxide synthases are elevated in dietary copper
deficiency. J. Nutr. Biochem. in press.
19
32.
33.
34.
35.
36.
37.
Wu S, Fang CX, Kim J, Ren J. Enhanced pulmonary inflammation following
experimental intracerebral hemorrhage. Exp. Neurol. 200: 245-249, 2006.
Wu S, Li Q, Du M, Li SY, Ren J. Cardiac overexpression of catalase prolongs lifespan,
attenuates aging-induced cardiomyocyte contractile dysfunction and protein damage.
Clin. Exp. Pharm. Physiol. 34: 81-87, 2007.
Xu P, Li SY, Li Q, Ren J, Van Kirk EA, Murdoch WJ, Radosz M, Shen Y.
Biodegradable cationic polyester as an efficient carrier for gene delivery to neonatal
cardiomyocytes. Biotechnology and Bioengineering 95:893-903, 2006.
Yang X, Li SY, Dong F, Ren J, Sreejayan N. Insulin-sensitizing and cholesterol
lowering effects of chromium (phenylalanine)3. J. Inorganic Biochem. 100:1187-1193,
2006.
Zhang QJ, Li QX, Zhang HF, Zhang KR, Guo WY, Wang HC, Fan M, Zhou Z, Cheng
HP, Ren J, Gao F. Aerobic exercise sensitizes myocardial contractile response to
insulin - Role of Akt-dependent eNOS activation. Cardiovasc Res. in press.
Zou XW, Wu S, Ren J. Systemic inflammatory response after stroke. Int. J.
Cerebrovasc Dis 14: 537-542, 2006.
B. BOOK EDITED
Molecular Medicine - Vascular Biology Protocols, edited by N. Sreejayan and J. Ren
(Humana Press 2007)
C.
NATIONAL/INTERNATIONAL
CONFERENCE
PRESENTATIONS
(*PRESENTOR):
1. Culver B*, Zhang X, Bruch D, Mayer GE, Shandera M. α-Benzyl-NMethylphenethylamine, an impurity of illicit methamphetamine synthesis, augments
methamphetamine-induced neurotoxicity via inhibition of cytochrome P450 2D6.
Society of Neuroscience Meeting, 2006, Soc. Neurosci. Abst. 293.4/PP18, 2006
(poster).
2. Fang CX*, Dong F, Nunn FM, Ren J. Metallothionein transgene prevents insulin
resistance-induced cardiac contractile dysfunction by promoting mitochondrial
biogenesis through upregulation of peroxisome proliferator-activated receptor gamma
coactivator-1 (PGC-1) alpha. American Heart Association 2006 Scientific Meeting,
Circulation 114: II-843, 2006 (oral).
3. Li Q*, Wu S, Li SY, Lopez FL, Kajstura J, Anversa P, Ren J. Cardiac overexpression
of insulin-like growth factor-1 attenuates senescence-associated cardiac diastolic
contractile dysfunction and protein damage. 15th Word Congress of Pharmacology
(IUPHAR-2006), Beijing, China (poster).
4. Li SY*, Xu P, Babcock SA, Shen Y, Ren J. Advanced glycation endproduct (AGE) is
linked to cardiomyocyte contractile dysfunction in streptozotocin-induced diabetic
mice. The 15th Word Congress of Pharmacology (IUPHAR-2006), Beijing, China
(poster).
5. Ren J*, Relling DP, Esberg LB, Zhao BH. Dietary influence of high fat and marginal
copper deficiency on cardiac contractile function in isolated cardiomyocytes. The 15th
Word Congress of Pharmacology (IUPHAR-2006), Beijing, China (poster).
20
6. Ren J*. Oxidative stress and alcoholic cardiomyopathy, Satellite Meeting of the 15th
IUPHAR (World Congress) on Cardiovascular Pharmacology, Suzhou, China 2006
(oral).
7. Ren J*. Use of transgenic models of ADH and ALDH, Novartis (formerly Ciba)
Foundation Symposium on “Acetaldehyde related pathology: Bridging the transdisciplinary divide”, London, UK, September 2006 (oral).
8. Zhang QJ, Lia QX, Zhang HF, Zhang KR, Guo WY, Wang HC, Ren J, Gao F*. Longterm aerobic exercise sensitizes myocardial contractile response to insulin: Role of Aktdependent eNOS activation. American Heart Association 2006 Scientific Meeting,
Circulation 114:II-299, 2006 (poster).
9. Sreejayan, N. and Ren J. Inhibitory Effect of Dehydrozingerone on Vascular Smooth
Muscle Cell Functions, Experimental Biology Meeting, Washington DC April 27-May
2, 2007. Abstract: FASEB J. (2007) 21: lb259
D.
SEMINARS PRESENTED:
1. Dong F: “Role of leptin in obesity associated heart diseases”, Zoology and
Physiology Journal Club, UW, October, 2006.
2. Ren J: “Use of transgenic models of ADH and ALDH”, Novartis (formerly Ciba)
Foundation Symposium on “Acetaldehyde related pathology: Bridging the transdisciplinary divide”, London, UK, September 2006.
3. Ren J: “Insulin signaling, oxidative stress and diabetic heart”, Zoology and
Physiology Journal Club, UW, April 2006.
.
21